DNAPrint Genomics, Inc. (DNAG)

DNAPrint Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002
Period Ending	Feb 12, 2026	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
Market Capitalization	0	4	3	9	36	14
Market Cap Growth	-99.86%	20.51%	-63.86%	-75.74%	165.28%	-34.48%
Enterprise Value	-	10	5	8	36	14
Last Close Price	0.00	0.01	0.02	0.22	1.38	0.60
PS Ratio	0.00	1.56	2.47	11.09	50.62	73.37
PB Ratio	0.00	-1.02	-0.77	91.21	-17.63	-12.26
P/TBV Ratio	-	-	-	91.60	-	-
EV/Sales Ratio	-	4.29	3.94	10.48	50.50	75.62
Debt / Equity Ratio	-0.63	-1.96	-0.26	6.58	-0.41	-0.79
Net Debt / Equity Ratio	-0.62	0.33	0.18	-3.66	-0.28	-0.77
Net Debt / EBITDA Ratio	-0.90	0.15	0.17	0.11	-0.09	-0.35
Net Debt / FCF Ratio	-1.21	0.20	0.20	0.09	-0.51	-0.54
Asset Turnover	0.51	0.29	0.32	0.51	0.83	0.27
Inventory Turnover	6.12	8.50	5.22	-	-	-
Quick Ratio	0.14	0.62	0.19	0.65	0.28	0.01
Current Ratio	0.17	0.64	0.25	0.90	0.39	0.02
Return on Assets (ROA)	-105.00%	-66.85%	-71.93%	-135.33%	-455.41%	-240.23%
Return on Capital Employed (ROCE)	77.60%	253.00%	124.70%	-1516.70%	497.30%	236.60%
Earnings Yield	-351412.66%	-325.41%	-276.79%	-42.86%	-21.69%	-22.99%
FCF Yield	-332497.92%	-162.68%	-118.44%	-43.85%	-3.12%	-11.73%
Buyback Yield / Dilution	-74.44%	-290.50%	-164.41%	-41.61%	-10.69%	-12.62%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.